Intramuscular Ketamine for Suicidal Patients in the Evanston Hospital Emergency Department for Suicidal Distress
NCT07810023 · KEDS-C · Endeavor Health
What it is testing
Summary
Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.
What counts as success
Primary outcome measures
Difference in time spent in the ED for dosing participants vs non-dosing patients
Measured over Up to 7 Days
Average dosing participants' scores of investigator-developed feasibility and acceptability survey.
Measured over Up to 7 days
Average ER personnel score of investigator-developed feasibility and acceptability survey
Measured over Up to 7 days
A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.
Who can take part
Eligibility, as published
Where
1 study site
| Facility | City | Region | Country |
|---|---|---|---|
| Endeavor Health Evanston Hospital | Evanston | Illinois | United States |
On the registry
Contact the trial directly
This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.
Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.
NCT07810023 on ClinicalTrials.gov →
Last updated in the registry 2026-09-09. Registry records change; this page reflects the data build of 2026-09-24.
Related
Where this trial sits
Substance
Recruiting in